Total Payments
$808.18
2022 Payments
$38.19
Companies
12
Transactions
48
Medicare Patients
4,425
Medicare Billing
$254,746
Payment Breakdown by Category
Food & Beverage$808.18 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $808.18 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $176.05 | 9 | $0 (2019) |
| Amgen Inc. | $145.51 | 8 | $0 (2022) |
| Novo Nordisk Inc | $141.44 | 10 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $122.50 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $54.95 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $32.94 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $31.92 | 2 | $0 (2019) |
| Allergan Inc. | $28.00 | 2 | $0 (2017) |
| Lilly USA, LLC | $25.41 | 2 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $16.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $38.19 | 2 | Amgen Inc. ($38.19) |
| 2019 | $194.15 | 11 | Janssen Pharmaceuticals, Inc ($102.97) |
| 2018 | $324.19 | 19 | Janssen Pharmaceuticals, Inc ($73.08) |
| 2017 | $251.65 | 16 | Novo Nordisk Inc ($67.93) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Bone Health | ||||||
| 09/19/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Bone Health | ||||||
| 11/27/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Diabetes | ||||||
| 09/13/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Neuroscience | ||||||
| 08/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
| 06/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Neuroscience | ||||||
| 04/26/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 03/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/19/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: UROLOGY | ||||||
| 12/14/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: UROLOGY | ||||||
| 11/09/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Diabetes | ||||||
| 10/05/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Neuroscience | ||||||
| 09/21/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Diabetes | ||||||
| 08/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/27/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/20/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Diabetes | ||||||
| 06/22/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/08/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/18/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 666 | 783 | $129,606 | $52,204 |
| 2022 | 15 | 1,136 | 1,347 | $213,452 | $51,913 |
| 2021 | 18 | 1,240 | 1,407 | $219,915 | $57,644 |
| 2020 | 19 | 1,383 | 1,546 | $212,161 | $92,985 |
Total Patients
4,425
Total Services
5,083
Medicare Billing
$254,746
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 213 | $51,120 | $18,110 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 101 | 101 | $23,735 | $12,253 | 51.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 36 | $13,320 | $4,807 | 36.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 46 | 47 | $7,285 | $3,499 | 48.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 27 | $6,750 | $2,474 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 34 | $5,950 | $2,071 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 32 | $5,120 | $1,739 | 34.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 94 | 94 | $4,136 | $1,621 | 39.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 94 | 94 | $2,820 | $1,621 | 57.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 13 | $2,535 | $1,142 | 45.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,635 | $968.88 | 59.3% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 29 | 29 | $2,320 | $919.88 | 39.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 13 | $1,690 | $804.18 | 47.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $1,190 | $174.40 | 14.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 66 | $24,420 | $10,312 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 162 | 279 | $66,960 | $8,573 | 12.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 128 | 128 | $30,080 | $5,209 | 17.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 64 | $12,520 | $5,156 | 41.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 76 | $10,240 | $4,269 | 41.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 49 | 49 | $8,085 | $3,442 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 94 | $15,040 | $2,625 | 17.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 128 | 128 | $5,632 | $2,309 | 41.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 127 | 127 | $3,810 | $2,253 | 59.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 27 | 27 | $5,265 | $2,221 | 42.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 25 | 28 | $3,640 | $1,578 | 43.4% |
About Dr. Bobby Paul, M.D
Dr. Bobby Paul, M.D is a Internal Medicine healthcare provider based in Parma, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902852148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bobby Paul, M.D has received a total of $808.18 in payments from pharmaceutical and medical device companies, with $38.19 received in 2022. These payments were reported across 48 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($808.18).
As a Medicare-enrolled provider, Paul has provided services to 4,425 Medicare beneficiaries, totaling 5,083 services with total Medicare billing of $254,746. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Parma, OH
- Active Since 05/26/2006
- Last Updated 09/04/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902852148
Products in Payments
- XARELTO (Drug) $158.72
- SOLIQUA (Drug) $86.65
- Victoza (Drug) $57.20
- Aimovig (Biological) $55.93
- ENTRESTO (Drug) $54.95
- Tresiba (Drug) $41.30
- EVENITY (Biological) $38.19
- Repatha (Biological) $37.01
- MYRBETRIQ (Drug) $31.92
- Ozempic (Drug) $31.67
- TRULICITY (Drug) $25.41
- JANUVIA (Drug) $18.33
- PRALUENT (Drug) $17.98
- TOUJEO (Drug) $17.87
- INVOKANA (Drug) $17.33
- Xtampza ER (Drug) $16.67
- SYMPROIC (Drug) $16.57
- BRISDELLE (Drug) $16.22
- NAMZARIC (Drug) $14.72
- SIVEXTRO (Drug) $14.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parma
Dr. Charles Koepke, Md, MD
Internal Medicine — Payments: $10,439
Internal Medicine $10,439
Jason Ice, Do, DO
Internal Medicine — Payments: $10,215
Internal Medicine $10,215
Florin Penciu, Md, MD
Internal Medicine — Payments: $9,339
Internal Medicine $9,339
Dr. Boris Gliner, M.d, M.D
Internal Medicine — Payments: $7,878
Internal Medicine $7,878
Dr. Morgan Koepke, Md, MD
Internal Medicine — Payments: $7,488
Internal Medicine $7,488
Amir Naraghi, Md, MD
Internal Medicine — Payments: $4,620
Internal Medicine $4,620